Personalized Cancer Vaccines
Explore peptide research and guides on personalized cancer vaccines.
Personalized Cancer Vaccines
KRAS Peptide Vaccines: Targeting Cancer's Top Mutation
KRAS mutations drive 25% of all cancers. Peptide vaccines targeting mutant KRAS are now in clinical trials for pancreatic, colorectal, and lung cancer.
Personalized Cancer VaccinesPeptide Vaccines Plus Checkpoint Inhibitors
How peptide cancer vaccines paired with PD-1 and CTLA-4 checkpoint inhibitors produce stronger antitumor immune responses than either therapy alone, with clinical trial data.
Personalized Cancer VaccinesPersonalized Cancer Vaccines: Neoantigen Peptides
Neoantigen peptide vaccines use your tumor's unique mutations to train T cells against cancer. Here is where the clinical trials stand in 2026.